| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0007 |